Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ettore Marubini

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Gynecologic Oncology|June 25, 2002
Effect of fenretinide on ovarian carcinoma occurrenceGiuseppe De Palo, Luigi Mariani, Tiziana Camerini, et al.
Clinical Chemistry and Laboratory Medicine|May 19, 2005
An Italian program of external quality control for quantitative assays based on real-time PCR with Taq-Man probesClaudia Casini Raggi, Paolo Verderio, Mario Pazzagli, et al.
Cancer|February 25, 2003
Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla?Gabriele Martelli, Rosalba Miceli, Giuseppe De Palo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancerAngela Moliterni, Sylvie Ménard, Pinuccia Valagussa, et al.
Clinical Chemistry|June 3, 2006
EQUAL-quant: an international external quality assessment scheme for real-time PCRSimon C Ramsden, Sarah Daly, Wolf-Jochen Geilenkeuser, et al.
Clinical Chemistry|June 22, 2007
EQUAL-qual: a European program for external quality assessment of genomic DNA extraction and PCR amplificationClaudio Orlando, Paolo Verderio, Ronald Maatman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patientsPatrizia Querzoli, Massimo Pedriali, Rosa Rinaldi, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Gynecologic Oncology|June 25, 2002
Effect of fenretinide on ovarian carcinoma occurrenceGiuseppe De Palo, Luigi Mariani, Tiziana Camerini, et al.
Clinical Chemistry and Laboratory Medicine|May 19, 2005
An Italian program of external quality control for quantitative assays based on real-time PCR with Taq-Man probesClaudia Casini Raggi, Paolo Verderio, Mario Pazzagli, et al.
Cancer|February 25, 2003
Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla?Gabriele Martelli, Rosalba Miceli, Giuseppe De Palo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancerAngela Moliterni, Sylvie Ménard, Pinuccia Valagussa, et al.
Clinical Chemistry|June 3, 2006
EQUAL-quant: an international external quality assessment scheme for real-time PCRSimon C Ramsden, Sarah Daly, Wolf-Jochen Geilenkeuser, et al.
Clinical Chemistry|June 22, 2007
EQUAL-qual: a European program for external quality assessment of genomic DNA extraction and PCR amplificationClaudio Orlando, Paolo Verderio, Ronald Maatman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patientsPatrizia Querzoli, Massimo Pedriali, Rosa Rinaldi, et al.
Pageof 3